Login to Write a Post
Current Positions - September 4, 2021
This is an update to my previous post: https://stonks.chat/group/4/posts/170
I've traded in/out/averaged/etc
$DTIL @ 11.97 (sold some above 14, then bought some back - exiting prior to September 9...I think)
$EDIT @ 58.20 (wrote some calls, bought some calls, bought some more shares - exiting prior to September 27)
$GRTS @ 10.97 (I think this is round 3, it's been a great one from the 6's - my biggest mistake has been underestimating the strength - exiting prior to September 17 - but it's got a few more events before EOY)
Researching: CRBU, CRTX, VERV
I've traded in/out/averaged/etc
$DTIL @ 11.97 (sold some above 14, then bought some back - exiting prior to September 9...I think)
$EDIT @ 58.20 (wrote some calls, bought some calls, bought some more shares - exiting prior to September 27)
$GRTS @ 10.97 (I think this is round 3, it's been a great one from the 6's - my biggest mistake has been underestimating the strength - exiting prior to September 17 - but it's got a few more events before EOY)
Researching: CRBU, CRTX, VERV
AERI
So a friend of mine just put me on to AERI. It's a company that makes treatments for glaucoma and other eye diseases. Allegedly this one is supposed to double from its current lows to about $24 over the next few months. This is likely because they have a couple of promising drugs undergoing trials. Use this quarterly report as the start of your DD:
investors.aeriepharma.com/node...
investors.aeriepharma.com/node...
DFFN - Diffusion Pharmaceuticals - COVID play for Q3/Q4 2020
DFFN
- Currently 1.47 (Monday close, +23% from Friday)
- 60M o/s & float
- $19M cash (probably good for another 8 mo)
- Dosing to start on COVID trials in July with data in Q3
- This is the PR that started this run: https://www.benzinga.com/pressreleases/20/05/g16104691/diffusion-pharmaceuticals-receives-accelerated-fda-response-to-proposed-tsc-covid-19-clinical-tria
- Actually sounds sensible: https://www.diffusionpharma.com/product-pipeline/overview-trans-sodium-crocetinate-tsc/
HTBX - Heat Biologics - COVID play
HTBX
- Currently 2.46 (Friday close)
- 84M o/s, 79M float
- $20M cash - decent runway
- Due to release news on COVID this month: https://ir.heatbio.com/press-releases
- Jeff Wolf, CEO of Heat, commented, “We remain on track to complete design and development of our COVID-19 vaccine in July, and expect that our gp96/nCoV-2 expressing cell line will be available for clinical-grade manufacturing with our partner, Waisman Biomanufacturing, in early August. Given our progress to date, we remain encouraged by the potential of our unique vaccine to provide broad cellular T-cell and humoral protection against COVID-19, as well as possible future mutations or other coronaviruses.”
- I'd be interested in anything under $2.00, I saw this at 1.00 last Monday 🤦♂️
VXRT - Influenza data & Operation Warp Speed
VXRT - currently 8.04 (but was around 9.00 in after hours)
- O/S 79M, 49M float
- Universal influenza vaccine Phase 1 data due by June 30
- New CEO - Andrei Floroiu - as of June 15
- They put out a PR every day except Monday last week - https://investors.vaxart.com/press-releases
- The mega news was obviously being picked for the Warp Speed Program https://investors.vaxart.com/news-releases/news-release-details/vaxarts-covid-19-vaccine-selected-us-governments-operation-warp
- Big difference for VXRT is theirs is oral vs everybody else’s is injection
- Everything about this deal looks like NVAX all over again
- Next announcement on Warp Speed for VXRT should be how much funding they’re getting. Something like this: https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html
- They’d be crazy not to do an offering in the next 30 days, I suspect they will. This would be to fund the non-COVID stuff.
- I think this will be 15-20 on the government funding announcement (Monday/Tuesday?), then dip down below 12-13 for a while after the Influenza data is out (this week) and then pick back up once they actually start the covid trials and largely just follow NVAX path. Just go back to Feb 26, 2020 on NVAX chart to see what the chart should look like over the next 3-4 months (not chart below stops at end of April, zoomed in..). 40+ by end of summer, I think.
Biotech Swings 👨⚕️💉
| Created By: | Maverick |
| Created: | Jun 25, 2020 |
| Total Followers: | 5 |
| Follow | |
The strategy here is simple: take 3 to 60 day positions in biotechs that have upcoming catalysts (data readouts, approvals, etc).
Offerings are the major danger, so always be mindful of cash position of the company you're trading.
Offerings are the major danger, so always be mindful of cash position of the company you're trading.
Link Copied to Clipboard!